AVAVA is a medical aesthetics platform advancing a new class of image-guided, focused intradermal laser products that are safe and effective for all skin tones. Its flagship product, MIRIA, uses proprietary Focal Point Technology™ to deliver energy with pinpoint accuracy anywhere in the skin to enhance skin revitalization outcomes. The platform combines advanced skin imaging with patented focal point technology to deliver energy at precise therapeutic depths, enabling unprecedented customization. AVAVA has a deep pipeline of products and board-approved ambitious global expansion plans. The company secured $35 million in new financing to accelerate commercialization of MIRIA and to advance next-generation products. Leadership includes CEO Dr. Irina Erenburg and scientific founders Drs. R. Rox Anderson, Dieter Manstein, and Henry Chan; AVAVA was born out of Blossom Innovations.

Total raised

$35M

Funding rounds

2

Latest round

Series C

Latest activity

Jun 2024